{"id":56306,"date":"2023-04-27T18:04:31","date_gmt":"2023-04-27T16:04:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/"},"modified":"2023-04-27T18:04:31","modified_gmt":"2023-04-27T16:04:31","slug":"spok-sets-date-to-report-first-quarter-2023-results","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/","title":{"rendered":"Spok Sets Date to Report First Quarter 2023 Results"},"content":{"rendered":"
\n

ALEXANDRIA, Va.–(BUSINESS WIRE)–Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced it will release its first quarter 2023 operating results on Wednesday, May 3, 2023, after the close of the U.S. financial markets.<\/p>\n

<\/a><\/p>\n

\nManagement will host a conference call and webcast to discuss these financial results on Thursday, May 4, 2023, at 9:30 a.m. ET. The presentation is open to all interested parties and may include forward-looking information.<\/p>\n

\nConference Call Details<\/b><\/p>\n\n\n\n\n\n
\n

\nDate\/Time<\/p>\n<\/td>\n

\n

\nThursday, May 4, 2023, at 9:30 a.m. ET<\/p>\n<\/td>\n<\/tr>\n

\n

\nWebcast:<\/p>\n<\/td>\n

\n

\nhttps:\/\/www.webcast-eqs.com\/register\/spok_q12023_en\/en<\/a><\/p>\n<\/td>\n<\/tr>\n

\n

\nU.S. Toll-Free Dial In:<\/p>\n<\/td>\n

\n

\n877-407-0890<\/p>\n<\/td>\n<\/tr>\n

\n

\nInternational Dial In:<\/p>\n<\/td>\n

\n

\n+1-201-389-0918<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nTo access the call, please dial in approximately ten minutes before the start of the call. For those unable to join the live call, an OnDemand version of the webcast will be available following the call under the URL link and on the investor relations website.<\/p>\n

\nInvestor Day Program<\/b><\/p>\n

\nFollowing the call, Spok will host an Investor Day with financial analysts and institutional investors, from 11:00 a.m. ET to 3:00 p.m. ET (10:00 a.m. CT to 2:00 p.m. CT), at the Ritz-Carlton Hotel in Dallas, TX. Spok\u2019s executive leadership team will present an updated view of the company\u2019s long-term strategy and capital allocation plans, followed by a live Q&A session. To register to attend the Investor Day, either in-person or via the live webcast, please visit the investor relations page of the Company\u2019s website at https:\/\/investors.spok.com\/<\/a>. A replay of the Investor Day presentation will also be accessible on the Company\u2019s website.<\/p>\n

\nAbout Spok<\/b><\/p>\n

\nSpok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headquartered in Alexandria, Virginia, is proud to be a global leader in healthcare communications. We deliver clinical information to care teams when and where it matters most to improve patient outcomes. Top hospitals rely on Spok Care Connect\u00ae platforms to enhance workflows for clinicians and support administrative compliance. Our customers send over 100 million messages each month through their Spok\u00ae solutions. Spok enables smarter, faster clinical communication. For more information, visit spok.com<\/a> or follow @spoktweets<\/a> on Twitter.<\/p>\n

\nSpok is a trademark of Spok Holdings, Inc. Spok Care Connect and Spok Mobile are trademarks of Spok, Inc.<\/p>\n

Contacts<\/b> <\/p>\n

\nAl Galgano
\n
952-224-6096
\n
Al.galgano@spok.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ALEXANDRIA, Va.–(BUSINESS WIRE)–Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced it will release its first quarter 2023 operating results on Wednesday, May 3, 2023, after the close of the U.S. financial markets. Management will host a conference call and webcast to discuss these financial results on Thursday, May 4, 2023, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56306","6":"format-standard","7":"category-industry"},"yoast_head":"\nSpok Sets Date to Report First Quarter 2023 Results - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spok Sets Date to Report First Quarter 2023 Results - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ALEXANDRIA, Va.–(BUSINESS WIRE)–Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced it will release its first quarter 2023 operating results on Wednesday, May 3, 2023, after the close of the U.S. financial markets. Management will host a conference call and webcast to discuss these financial results on Thursday, May 4, 2023, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-27T16:04:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230427005758\/en\/1776964\/21\/Spok-logo-clr.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Spok Sets Date to Report First Quarter 2023 Results\",\"datePublished\":\"2023-04-27T16:04:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/\"},\"wordCount\":392,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005758\\\/en\\\/1776964\\\/21\\\/Spok-logo-clr.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/\",\"name\":\"Spok Sets Date to Report First Quarter 2023 Results - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005758\\\/en\\\/1776964\\\/21\\\/Spok-logo-clr.jpg\",\"datePublished\":\"2023-04-27T16:04:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005758\\\/en\\\/1776964\\\/21\\\/Spok-logo-clr.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005758\\\/en\\\/1776964\\\/21\\\/Spok-logo-clr.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spok-sets-date-to-report-first-quarter-2023-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spok Sets Date to Report First Quarter 2023 Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spok Sets Date to Report First Quarter 2023 Results - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/","og_locale":"en_US","og_type":"article","og_title":"Spok Sets Date to Report First Quarter 2023 Results - Pharma Trend","og_description":"ALEXANDRIA, Va.–(BUSINESS WIRE)–Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced it will release its first quarter 2023 operating results on Wednesday, May 3, 2023, after the close of the U.S. financial markets. Management will host a conference call and webcast to discuss these financial results on Thursday, May 4, 2023, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-27T16:04:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230427005758\/en\/1776964\/21\/Spok-logo-clr.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Spok Sets Date to Report First Quarter 2023 Results","datePublished":"2023-04-27T16:04:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/"},"wordCount":392,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230427005758\/en\/1776964\/21\/Spok-logo-clr.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/","url":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/","name":"Spok Sets Date to Report First Quarter 2023 Results - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230427005758\/en\/1776964\/21\/Spok-logo-clr.jpg","datePublished":"2023-04-27T16:04:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230427005758\/en\/1776964\/21\/Spok-logo-clr.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230427005758\/en\/1776964\/21\/Spok-logo-clr.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/spok-sets-date-to-report-first-quarter-2023-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Spok Sets Date to Report First Quarter 2023 Results"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56306","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56306"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56306\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56306"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56306"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}